MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticobasal degeneration (CBD)"

  • 2019 International Congress

    Baseline analysis of PROSPECT-M-UK: a longitudinal study of PSP, CBS and MSA

    E. Jabbari, J. Woodside, V. Chelban, A. Costantini, N. Holland, N. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, J. Rowe, H. Morris (London, United Kingdom)

    Objective: To complete the baseline analysis of clinical data from the PROSPECT-M-UK study and to assess the impact of applying current MDS PSP diagnostic criteria…
  • 2019 International Congress

    Cerebellar involvement in progressive supranuclear palsy and corticobasal degeneration

    S. Jo, KW. Park, N. Choi, CS. Lee, MS. Kim (Seoul, Republic of Korea)

    Objective: To investigate cerebellar involvement in vivo in patients with corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) using [18F]FDG PET. Background: Cerebellar ataxia is…
  • 2019 International Congress

    Exploratory Analysis of Electrocortical Signal Complexity in Patients with Progressive Supranuclear Palsy and Corticobasal Degeneration

    G. Mostile, L. Giuliano, R. Terranova, A. Luca, G. Donzuso, G. Portaro, C. Rascunà, V. Sofia, A. Nicoletti, M. Zappia (Catania, Italy)

    Objective: We evaluated self-similarity of electrocortical activity as expression of brain signal complexity in patients clinically affected by Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration…
  • 2019 International Congress

    Phenotypic spectrum of Progressive Supranuclear Palsy in a Tunisian cohort

    A. Nasri, A. Neji, I. Kacem, T. Lansari, S. Mrabet, A. Gargouri, M. Ben Djebara, R. Gouider (Tunis, Tunisia)

    Objective: To describe the clinical and imaging features of the different phenotypes of progressive supranuclear palsy (PSP). Background: PSP is a neuropathologically defined disease entity…
  • 2019 International Congress

    Deciphering Corticobasal Syndrome: are clinical features and FDG-PET imaging capable of predicting amiloyd status?

    J. Parmera, A. Coutinho, A. Neto, M. Aranha, C. Ono, C. Buchpiguel, R. Nitrini, E. Barbosa, S. Brucki (São Paulo, Brazil)

    Objective: The present study aimed at establishing clinical and brain functional patterns at FDG-PET that could distinguish Corticobasal Syndrome(CBS) variants due to AD from Tau pathology based on Pittsburgh Compound…
  • 2019 International Congress

    Posterior cortical atrophy (PCA) attributable to corticobasal degeneration

    H. Sienkiewicz-Jarosz, E. Bucior (Warsaw, Poland)

    Objective: Introduction: PCA is a clinico-radiological syndrome characterized by progressive decline in visual processing and other posterior cognitive functions, relatively intact memory and language in…
  • 2018 International Congress

    Antiglycine Receptor Antibodies and Rapidly Progressive Corticobasal Syndrome

    A. Muñoz González, A. Contreras Chicote, M. Vales Montero, J.M. Velázquez Pérez, B. Dela Casa, E. Luque Buzo, F. Graus, F. Grandas (Madrid, Spain)

    Objective: To describe the first case of non-paraneoplastic autoimmune encephalitis with antiglycine receptor (anti-GlyR) antibodies manifesting as a Corticobasal Syndrome (CBS) and the response to…
  • 2018 International Congress

    Clinical features and natural history of pathologically-confirmed corticobasal degeneration: A Japanese validation study of CBD (J-VAC study)

    I. Aiba, T. Shimohata, S. Murayama, K. Hasegawa, Y. Iwasaki, O. Yokota, H. Fujimura, M. Sakai, T. Yokota, I. Yabe, H. Takigawa, K. Sugaya, K. Mori, M. Ito, C. Ishida, M. Kobayashi, Y. Hashizume, T. Ikeuchi, M. Hasegawa, M. Yoshida, T. Komori, K. Wakabayashi, Y. Saito, A. Tokumaru, K. Sakurai, K. Nakashima (Nagoya, Japan)

    Objective: To elucidate the clinical features and natural history of CBD. Background: Recently, various clinical phenotypes of corticobasal degeneration (CBD) have been reported; on the…
  • 2018 International Congress

    Usefulness of combined examination using Frontal Assessment Battery (FAB) and Single Photon Emission Computer Tomography in the differentiation of 4 repeats (4R) tauopathic atypical parkinsonism

    P. Alster, D. Koziorowski, L. Królicki, A. Friedman (Warsaw, Poland)

    Objective: The aim of the work is to analyze whether combined examination of the frontal lobe using single photon emission computer tomography (SPECT) and Frontal…
  • 2018 International Congress

    Referral and diagnostic time intervals from symptom onset to death in progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Parkinson’s disease (PD)

    D. Swallow, C. Counsell (Aberdeen, United Kingdom)

    Objective: To compare referral and diagnostic time intervals from index symptom to death in PSP/CBD and age-sex matched PD. Background: Misdiagnosis and delayed diagnosis are…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • #25136 (not found)
  • Unusual prolonged survival in multiple system atrophy: A case report
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley